SS-31 (Elamipretide/Lamipretide) as Highest-Impact Peptide for Mitochondrial Dysfunction and Muscular Dystrophy
Dr. Yurth identifies SS-31 (elamipretide/lamipretide) as the highest-impact peptide for muscular dystrophy and mitochondrial dysfunction, describing it as 'the most mechanistically sound peptide' for these conditions. The mechanism involves binding to cardiolipin on the inner mitochondrial membrane, allowing mitochondria to heal, recover, produce fewer reactive oxygen species, and restore ATP production. Pre-clinical (animal) data for muscular dystrophy shows significant benefits. For severe cases, high-dose or even IV administration may be warranted.